Article
The <i>RET</i> proto‐oncogene: A molecular therapeutic target in thyroid cancer
1 Mar 2005
Abstract excerpt
The RET proto-oncogene is responsible for the development of several human inherited and non-inherited diseases. Germline point mutations were identified in multiple endocrine neoplasia types 2A and 2B, and familial medullary thyroid carcinoma. More than 10 rearranged forms of RET, referred to as RET/PTC 1-9, ELKS/RET and RFP/RET, have been cloned from sporadic and radiation-associated papillary thyroid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
